Glyceryl trinitrate prevents neutrophil activation but not thromboxane release following ischaemia-reperfusion injury

被引:11
|
作者
Barry, MC [1 ]
Kelly, CJ [1 ]
Stokes, K [1 ]
Abdih, H [1 ]
Sheehan, S [1 ]
Burke, P [1 ]
Hayes, DB [1 ]
机构
[1] BEAUMONT HOSP,DEPT SURG,ROYAL COLL SURG IRELAND,DUBLIN 9,IRELAND
关键词
D O I
10.1002/bjs.1800830818
中图分类号
R61 [外科手术学];
学科分类号
摘要
The aim of this study was to determine whether glyceryl trinitrate (GTN) has a protective effect on neutrophil-mediated lung injury in a model of aortic occlusion (30 min) and reperfusion (120 min). Sprague-Dawley rats were randomized into control (n = 11), ischaemia-reperfusion (TR) (n = 12), and IR treated with GTN (2 mu g kg(-1) min(-1)) during reperfusion (n = 10). Myeloperoxidase (MPO) activity measured pulmonary neutrophil influx. Pulmonary endothelial permeability was measured by wet:dry weight ratio, bronchoalveolar lavage (BAL) protein and neutrophil counts. Neutrophil superoxide release was measured by flow cytometry in a further IR versus GTN experiment (n = 6 in each group). The significant increase in MPO activity produced by IR to a level of 7.99 units g(-1) was prevented by GTN which reduced the level to 4.73 units g(-1). The increase in pulmonary microvascular leakage after reperfusion was also prevented by GTN: BAL protein without GTN was 992 mu g ml(-1) and with GTN 579 mu g ml(-1); BAL neutrophil count without GTN was 3219 cells mm(-3) and with GTN 820 cells mm(-3); the wet:dry lung weight ratio without GTN was 3.8 and with GTN 3.3. Neutrophil superoxide release increased significantly after 40 min of reperfusion in the untreated IR group (P<0.05). This increase was prevented in the GTN-treated group. GTN administration had no effect on plasma thromboxane production during revascularization. These data suggest that GTN administration during the reperfusion phase has the potential to decrease pulmonary microvascular injury.
引用
收藏
页码:1095 / 1100
页数:6
相关论文
共 50 条
  • [31] Effects of levosimendan on myocardial ischaemia-reperfusion injury
    Yapic, D.
    Altunkan, Z.
    Ozerent, M.
    Bilgln, E.
    Balli, E.
    Tamer, L.
    Doruk, N.
    Birbicer, H.
    Apa, D.
    Oral, U.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2008, 25 (01) : 8 - 14
  • [32] Octreotide reduces ischaemia-reperfusion injury in the retina
    Celiker, U
    Ilhan, N
    Ozercan, I
    Demir, T
    Celiker, H
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2002, 80 (04): : 395 - 400
  • [33] Resistin worsens cardiae ischaemia-reperfusion injury
    Rothwell, Sarah E.
    Richards, A. Mark
    Pemberton, Christopher J.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 349 (01) : 400 - 407
  • [34] The therapeutic role of taurine in ischaemia-reperfusion injury
    Kingston, R
    Kelly, CJ
    Murray, P
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (19) : 2401 - 2410
  • [35] Ischaemia-reperfusion injury - Implications for the hand surgeon
    Al-Qattan, MM
    JOURNAL OF HAND SURGERY-BRITISH AND EUROPEAN VOLUME, 1998, 23B (05): : 570 - 573
  • [36] Cold and warm intestinal ischaemia-reperfusion injury
    Shah, KA
    Shurey, S
    Green, CJ
    JOURNAL OF PATHOLOGY, 1998, 184 : 20A - 20A
  • [37] Endoglin regulates renal ischaemia-reperfusion injury
    Docherty, Neil G.
    Lopez-Novoa, Jose M.
    Arevalo, Miguel
    Duwel, Annette
    Rodriguez-Pena, Ana
    Perez-Barriocanal, Fernando
    Bernabeu, Carmelo
    Eleno, Nelida
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (08) : 2106 - 2119
  • [38] Kidney ischaemia-reperfusion injury and polyribosome structure
    Plestina, S
    Gamulin, S
    NEPHRON, 2001, 89 (02) : 201 - 207
  • [39] Pulmonary ischaemia-reperfusion injury: role of apoptosis
    Ng, CSH
    Wan, S
    Yim, APC
    EUROPEAN RESPIRATORY JOURNAL, 2005, 25 (02) : 356 - 363
  • [40] Dexmedetomidine attenuation of renal ischaemia-reperfusion injury requires sirtuin 3 activation
    Si, Y.
    Bao, H.
    Han, L.
    Chen, L.
    Zeng, L.
    Jing, L.
    Xing, Y.
    Geng, Y.
    BRITISH JOURNAL OF ANAESTHESIA, 2018, 121 (06) : 1260 - 1271